Miyai Yuki 宮井雄基

… Alternative Names

宮井雄基ミヤイユウキ

Less

Researcher Number	90883538
Other IDs	https://orcid.org/0000-0003-0386-1431
Affiliation (Current)	2025: 名古屋大学, 医学部附属病院, 病院助教
Affiliation (based on the past Project Information) *help	2025: 名古屋大学, 医学部附属病院, 病院助教 2023: 名古屋大学, 医学部附属病院, 医員 2020 – 2021: 名古屋大学, 医学部附属病院, 医員
Review Section/Research Field	Principal Investigator Basic Section 50010:Tumor biology-related / 0901:Oncology and related fields
Keywords	Principal Investigator がん関連線維芽細胞 / 補体C3 / 免疫療法 / がん微小環境 / がん間質 / 免疫治療 / がん免疫治療 / 効果増強 / 効果予測 / 免疫チェックポイント阻害剤 / がん

Research Projects
(3 results)
Research Products
(3 results)

全身vs局所補体C3の腫瘍免疫制御機構の解明Principal Investigator
- Principal Investigator
  
  宮井雄基
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Nagoya University
腫瘍微小環境局所で産生される補体が腫瘍免疫を制御する機構の解明とその制御法の開発Principal Investigator
- Principal Investigator
  
  宮井雄基
- Project Period (FY)
  2023 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Nagoya University
Enhance the efficacy of immune checkpoint inhibitors by targeting MeflinPrincipal Investigator
- Principal Investigator
  
  Miyai Yuki
- Project Period (FY)
  2020 – 2021
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Review Section
  
  0901:Oncology and related fields
- Research Institution
  Nagoya University

All 2023 2022 2020

All Journal Article Presentation

[Journal Article] Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade2022
- Author(s)
  Miyai Yuki、Sugiyama Daisuke、Hase Tetsunari、Asai Naoya、Taki Tetsuro、Nishida Kazuki、Fukui Takayuki、Chen-Yoshikawa Toyofumi Fengshi、Kobayashi Hiroki、Mii Shinji、Shiraki Yukihiro、Hasegawa Yoshinori、Nishikawa Hiroyoshi、Ando Yuichi、Takahashi Masahide、Enomoto Atsushi
- Journal Title
  
  Life Science Alliance
  
  Volume: 5 Issue: 6 Pages: e202101230-e202101230
- DOI
  10.26508/lsa.202101230
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K22807, KAKENHI-PROJECT-17H06162, KAKENHI-PROJECT-20H03528, KAKENHI-PROJECT-21K20821, KAKENHI-PROJECT-22K07000, KAKENHI-PROJECT-22H00455, KAKENHI-PROJECT-20H03467, KAKENHI-PROJECT-19K07503
[Presentation] Local complement C3 production by cancer-associated fibroblasts boosts anti-tumor immunity.2023
- Author(s)
  Miyai Y, Ando Y, Enomoto A
- Organizer
  Keystone Symposia, the resistant tumor microenvironment
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K14591
[Presentation] Significance of meflin-positive cancer-associated fibroblasts in predicting response to immune checkpoint inhibitors in non-small cell lung cancer.2020
- Author(s)
  Miyai Yuki、Enomoto Atsushi、Ando Yuichi、Takahashi Masahide
- Organizer
  ASCO2020
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K22807